This report describes the work done by WHO from January 2015 up to the end of December 2016 to address the long-term issues of survivor care, health-systems strengthening and research.
This is a detailed manual giving a step by step approach to undertaking the pharmacovigilance of antiretrovirals. It is intended to be a source of practical advice for Pharmacovigilance Centres and health professionals involved in HIV/AIDS prevention and treatment programmes. A number of WHO publica...tions are available that provide a background to pharmacovigilance and, as far as possible, that material will not be repeated here. Health officials, planners, the staff of Pharmacovigilance Centres, public health teams and all health workers should become familiar with these publications, which are: • Safety of Medicines: A guide to detecting and reporting adverse drug reactions
more
Program for Early Recovery and Resilience Building from EVD Outbreak in Liberia
Key populations brief
Accessed November 2017
Health Evidence Network synthesis report 53
January – December 2014
Republic of Moldova South‐East European Region National Coordination Council
Declaration of Commitment of the United Nations General Assembly Special Session on HIV/AIDS
Mid-term review of The National AIDS Programme 2011-15
October 2013
SDG target 3.3: by 2030, end the epidemics of AIDS, tuberculosis, malaria and neglected tropical diseases and combat hepatitis, waterborne diseases and other communicable diseases.
Morbidity and Mortality Weekly Report (MMWR) October 4, 2019 / 68(39);851–854
Editorial Review
AIDS 2019, 33:1411–1420
Overcoming HIV-related stigma and discrimination in health- care settings and beyond
UNAIDS 2017 | REFERENCE
Recommendations for a Public Health approach and considerations for policy-makers and managers
PLOS ONE | https://doi.org/10.1371/journal.pone.0196239 April 23, 2018
Child Survival Working Group
Accessed: 18.10.2019